κ-opioid receptor - Wikipedia
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Understanding opioids in veterinary medicine
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Κ-opioid receptor - an overview | ScienceDirect Topics
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
The Kappa Opioid Receptor | SpringerLink
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
Opioids in cancer: The κ‑opioid receptor (Review)
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Innovation – Cara Therapeutics
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
κ-Opioid Receptor (KOP) | 7TM Antibodies
κ-opioid receptor - Wikipedia
Mu Agonist Opioids and Kappa Opioids | Download Table
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
